BCL2 and ovarian carcinoma: Consistent with our hypothesis, it was recently shown that the Src/Abl kinases inhibitor Dasatinib arrested the growth of ovarian cancer xenograft by inducing BECLIN 1-dependent autophagic cell death, and hyperstimulation of autophagy was associated with downregulation of BCL-2 expression [30].